Categories: All postsAnalysts

TECSYS could double or triple, says Cantor Fitzgerald

Tecsys CEO Peter Brereton.

If the company keeps winning business at its current rate, TECSYS (TECSYS Stock Quote, Chart, News: TSX:TCS) shares could double or triple over the next three years, says Cantor Fitzgerald Canada analyst Justin Kew.

On Thursday, TECSYS will report its Q3, 2015 results. Kew expects it will post EBITDA of $1.4 million on revenue of $14.2-million. Both numbers are in line with the street consensus.

Kew notes that the company’s backlog increased to a record $34.7 million in the second quarter. He believes this is an indication of the its success in securing healthcare deals, particularly with integrated delivery network deals (IDNs). IDNs are a network of health care organizations that reside under a parent holding company.

The analyst explains that TECSYS has a lot of runway left in the healthcare vertical.

“TECSYS currently has a 5.3% IDN penetration rate, based on 16 contracted IDNs in a universe of approximately 300. In addition, management expects to grow to 20 IDNs (or 7% penetration) over the next two quarters. Management has stated in the past that each new IDN win generates approximately $1.5 million in revenue in the first year and approximately $5 million in revenue in the first four years. The incremental annual revenue between year 2 and year 4 is therefore approximately $1.2 million”.

Kew posits a number of scenarios for TECSYS’s growth. He notes that 38 IDN wins between fiscal 2016 and 2019 would earn TECSYS a 12.5% market penetration and generate fiscal 2019 revenue of $79-million. 53 wins, he says, would mean a 17.5% penetration and $96-million in revenue. And 68 wins would earn a 22.5% penetration and $113-million in revenue.

The other key factor in determining the upside of TECSYS is margins, says Kew. The company currently has 10% EBITDA margins, but management has stated it would like to increase this number to 20% in the long term. The analyst models a number of scenarios that combine IDN market share and margins. At his target of 15% margins, shares of TECSYS would be worth $19.37 under the middle scenario of 17.5% penetration.

In a research update to clients this morning, Kew maintained his “Buy” rating and one year target of $9.50 on TECSYS.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: tcs
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 hours ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

17 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

1 day ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

1 day ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

1 day ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago